Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

August 31, 2004

Conditions
Kidney Disease
Interventions
DRUG

Zemplar Capsule

Trial Locations (16)

32610

University of Florida, Gainesville

33908

Associates in Nephrology, Fort Meyers

34667

Outcomes Research International, Inc., Hudson

37205

Nephrology Associates, P.C., Nashville

46202

Indiana University School of Medicine, Indianapolis

60057

Georgetown University Medical Center, Washington D.C.

60201

Evanston Northwestern Healthcare, Evanston

63108

Washington University Medical Center, St Louis

63110

St. Louis University, St Louis

77030

Kidney Associates, PLLC, Houston

78229

University of Texas Health Center at San Antonio, San Antonio

89102

Nea Research, Las Vegas

92120

California Institute of Renal Research, San Diego

97210

Northwestern Renal Clinic, INC., Portland

70112-2699

Tulane University School of Medicine, New Orleans

45267-0585

University of Cincinnati College of Medicine, Cincinnati

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY